Verve Therapeutics Brand Score: 74/100 - Brand-Ready tier

Protecting the world from heart disease

Verve Therapeutics (vervetx.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 38th percentile of 13068 Healthcare brands.

AI Snapshot

Verve Therapeutics is an American pharmaceutical company headquartered at Technology Square. Its mission is to protect the world from cardiovascular disease, and it develops innovative treatments aimed at combating atherosclerotic cardiovascular disease (ASCVD) by targeting its underlying causes. The company positions itself as a pioneering biotechnology firm seeking transformative solutions to reduce the global burden of cardiovascular disease, serving patients at risk of or living with the condition, healthcare providers, and the broader medical and scientific community.

Key facts about Verve Therapeutics
Brand NameVerve Therapeutics
Domainvervetx.com
IndustryHealthcare
HeadquartersTechnology Square
Main CompetitorsBeam Therapeutics (76/100), Intellia Therapeutics (84/100), CRISPR Therapeutics (79/100), Regeneron Pharmaceuticals (92/100), Novartis (71/100), Amgen (90/100), Eli Lilly and Company (78/100)

Evidence

Moz Domain Authority 47/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.

Ranked #1,042,721 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.

Verve Therapeutics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.

The homepage meta description reads "We are on a mission to protect the world from cardiovascular disease." (Meta description: 12 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.

Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.

AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.

Detected tech stack: Cloudflare, Drupal.

Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.

0 Reddit mentions - community discussion signals real-world reputation to AI models.

Does AI know Verve Therapeutics?

Live results from asking a general-purpose AI assistant about the brand, checked October 2026.

When asked "What is Verve Therapeutics?", Claude could identify the brand as of October 2026. Verve Therapeutics is a biotech company developing gene-editing therapies aimed at treating cardiovascular disease through one-time treatments that permanently lower disease-causing lipids like LDL cholesterol, using base editing technology targeting genes such as PCSK9 and ANGPT Best known for Pioneering in vivo CRISPR base editing therapies to permanently reduce cardiovascular risk factors, most notably its PCSK9-targeting treatment.

When asked "Best brands similar to Verve Therapeutics?", Claude would recommend Verve Therapeutics as of October 2026. It's a notable name in gene-editing approaches to cardiovascular disease and would come up when discussing leaders in genetic medicine for heart health.

People Also Ask About Verve Therapeutics

Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.

Who are Verve Therapeutics's main competitors?

Verve Therapeutics's main competitors in Healthcare: Beam Therapeutics (76/100), Intellia Therapeutics (84/100), CRISPR Therapeutics (79/100), Regeneron Pharmaceuticals (92/100), Novartis (71/100).

Sources: Brand Analyzer scan

Where is Verve Therapeutics headquartered?

Verve Therapeutics is headquartered in Technology Square. Verve Therapeutics operates in the Healthcare category.

Sources: Wikidata

Does ChatGPT recommend Verve Therapeutics?

Verve Therapeutics scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.

Sources: Verve Therapeutics official site

How can Verve Therapeutics improve its AI discoverability?

Verve Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.

Sources: Verve Therapeutics official site

What is Verve Therapeutics?

Verve Therapeutics is an American pharmaceutical company focused on cardiovascular disease. It is described as a biotechnology company developing advanced therapeutic approaches intended to address the underlying causes of atherosclerotic cardiovascular disease (ASCVD).

Sources: Verve Therapeutics official site

What does Verve Therapeutics do?

Verve Therapeutics develops innovative treatments aimed at combating cardiovascular disease, the leading cause of death worldwide. Its therapeutic approaches are designed to target the underlying causes of conditions such as ASCVD, with the stated mission of protecting the world from cardiovascular disease.

Sources: Verve Therapeutics official site

Recommendations

AI visibility

Verve Therapeutics scores 50/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.

Verve Therapeutics has a limited AI-visibility profile at 50/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (61/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,042,721 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Verve Therapeutics from memory (October 2026) - a sign these signals are paying off.

Visibility - 61/100

Trust - 29/100

Recommendation likelihood - 57/100

Score breakdown - 7 dimensions

The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.

Peer brands

Ranked closest to Verve Therapeutics: Vedanta Biosciences (74/100), Vection Technologies (74/100), VetBadger (74/100), Ordre national des vétérinaires (74/100).

A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).

Category leader: Booksy (96/100).

Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.

Add this brand score badge to your site